https://www.selleckchem.com/pr....oducts/phosphoenolpy
Since the onset of the pandemic, only few studies focused on longitudinal immune monitoring in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) whereas their hospital stay may last for several weeks. Consequently, the question of whether immune parameters may drive or associate with delayed unfavorable outcome in these critically ill patients remains unsolved. We present a dynamic description of immuno-inflammatory derangements in 64 critically ill COVID-19 patients incl
Like
Comment
Share
